The Lyme Disease Diagnostic Market is on a path of substantial growth, with its global valuation estimated at approximately $12.49 billion in 2025 and projected to reach $27.65 billion by 2035. This expansion is driven by a steady compound annual growth rate (CAGR) of roughly 8.3%, reflecting the increasing global burden of tick-borne illnesses. For a comprehensive breakdown of market size, share, and long-term forecasts, you can explore the Lyme Disease Diagnostic Market report.

People also ask: What is the current market size of the Lyme disease testing industry? Why is the market for Lyme diagnostics growing? The rise is primarily fueled by climate change, which has expanded the geographic range of ticks, and an increase in outdoor recreational activities that elevate human exposure.

As diagnostic infrastructure improves in endemic regions, the market is shifting from traditional manual assays to automated, high-throughput systems. Strategic investments from public health agencies and private laboratory chains are ensuring that diagnostic services become more accessible, particularly in high-risk zones across North America and Europe.